On 12/10/20 the FDA reported that 4 out of 38,000 Pfizer trial participants developed BP. They deemed that nonsignificant, as it is comparable to the incidence of BP in the general population. Are we getting that news correctly? I’m a behavioral scientist, not a biotech scientist - but the message seems muddled somewhere.